Phenylketonuria differential diagnosis: Difference between revisions

Jump to navigation Jump to search
m (Categories)
 
(3 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Phenylketonuria}}
{{Phenylketonuria}}
{{CMG}}; {{AE}}
{{CMG}}; {{AE}} [[User:Yanira Gavidia|Yanira Gavidia, M.D.]]
 
==Overview==
==Overview==
Phenylketonuria must be differentiated from other causes of intellectual developmental disability, [[seizures]], [[anxiety]]/[[depression]], and characteristic [[urine odor]]s, such as other [[inborn errors of metabolism]], [[cerebral palsy]], inherited neurotransmitter disorders, and primary seizure disorders.


==Differential Diagnosis==
==Differential Diagnosis==
Conditions coursing with:
Phenylketonuria must be differentiated from other causes of intellectual developmental disability, seizures, anxiety/depression, and characteristic urine odors:<ref name="pmid25433678">{{cite journal| author=Leach EL, Shevell M, Bowden K, Stockler-Ipsiroglu S, van Karnebeek CD| title=Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review. | journal=Orphanet J Rare Dis | year= 2014 | volume= 9 | issue=  | pages= 197 | pmid=25433678 | doi=10.1186/s13023-014-0197-2 | pmc=PMC4273454 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25433678  }} </ref><ref name="pmid25758715">{{cite journal| author=Mercimek-Mahmutoglu S, Sidky S, Hyland K, Patel J, Donner EJ, Logan W et al.| title=Prevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: a retrospective cohort study. | journal=Orphanet J Rare Dis | year= 2015 | volume= 10 | issue= 1 | pages= 12 | pmid=25758715 | doi=10.1186/s13023-015-0234-9 | pmc=PMC4342151 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25758715  }} </ref><ref name="pmid25344299">{{cite journal| author=Zeltner NA, Huemer M, Baumgartner MR, Landolt MA| title=Quality of life, psychological adjustment, and adaptive functioning of patients with intoxication-type inborn errors of metabolism - a systematic review. | journal=Orphanet J Rare Dis | year= 2014 | volume= 9 | issue=  | pages= 159 | pmid=25344299 | doi=10.1186/s13023-014-0159-8 | pmc=PMC4219016 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25344299  }} </ref><ref name="pmid25205257">{{cite journal| author=Baumgartner MR, Hörster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA et al.| title=Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. | journal=Orphanet J Rare Dis | year= 2014 | volume= 9 | issue=  | pages= 130 | pmid=25205257 | doi=10.1186/s13023-014-0130-8 | pmc=PMC4180313 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25205257  }} </ref>
* <u>Intellectual developmental disability:</u> cerebral palsy, inborn errors of metabolism (IEM) such as fatty acid oxidation disorders, lysosomal disorders, hyperhomocysteinemias and amnio acid disorders, creatine deficiencies. <ref name="pmid25433678">{{cite journal| author=Leach EL, Shevell M, Bowden K, Stockler-Ipsiroglu S, van Karnebeek CD| title=Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review. | journal=Orphanet J Rare Dis | year= 2014 | volume= 9 | issue=  | pages= 197 | pmid=25433678 | doi=10.1186/s13023-014-0197-2 | pmc=PMC4273454 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25433678  }} </ref>
===Intellectual developmental disability===
* <u>Seizures:</u> Inherited neurotransmitter and non-neurotransmitter disorders, primary seizures.<ref name="pmid25758715">{{cite journal| author=Mercimek-Mahmutoglu S, Sidky S, Hyland K, Patel J, Donner EJ, Logan W et al.| title=Prevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: a retrospective cohort study. | journal=Orphanet J Rare Dis | year= 2015 | volume= 10 | issue= 1 | pages= 12 | pmid=25758715 | doi=10.1186/s13023-015-0234-9 | pmc=PMC4342151 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25758715  }} </ref>
*[[Cerebral palsy]]
* <u>Anxiety and/or depression</u>: IEM such as urea cycle disorders, organic acidurias, maple syrup urine disease, tyrosinemia type 1.<ref name="pmid25344299">{{cite journal| author=Zeltner NA, Huemer M, Baumgartner MR, Landolt MA| title=Quality of life, psychological adjustment, and adaptive functioning of patients with intoxication-type inborn errors of metabolism - a systematic review. | journal=Orphanet J Rare Dis | year= 2014 | volume= 9 | issue=  | pages= 159 | pmid=25344299 | doi=10.1186/s13023-014-0159-8 | pmc=PMC4219016 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25344299  }} </ref>
*[[Fatty acid oxidation disorder]]s
* <u>Characteristic urine odor</u>: maple syrup urine disease, methylmalonic and propionic acidemia.<ref name="pmid25205257">{{cite journal| author=Baumgartner MR, Hörster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA et al.| title=Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. | journal=Orphanet J Rare Dis | year= 2014 | volume= 9 | issue=  | pages= 130 | pmid=25205257 | doi=10.1186/s13023-014-0130-8 | pmc=PMC4180313 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25205257  }} </ref>
*Lysosomal disorders
*[[Hyperhomocysteinemia]]
*[[Amino acid disorder]]s
*Creatine deficiencies
===Seizures===
*Inherited neurotransmitter and non-neurotransmitter disorders
*Primary seizure disorders
===Anxiety and/or depression===
*[[Urea cycle disorder]]s
*[[Organic aciduria]]s
*[[Maple syrup urine disease]]
*[[Tyrosinemia]] type 1
===Characteristic urine odor===
*[[Maple syrup urine disease]]
*[[Methylmalonic acidemia]]
*[[Propionic acidemia]]


==References==
==References==
{{Reflist|2}}


{{Reflist|2}}
[[Category:Metabolic disorders]]
[[Category:Genetic disorders]]
[[Category:Congenital disorders]]
[[Category:Pediatrics]]
[[Category:Pediatrics]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Metabolism]]
[[Category:Endocrinology]]
[[Category:Inborn errors of metabolism]]
 
{{WS}}
{{WH}}

Latest revision as of 13:12, 26 July 2016

Phenylketonuria Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Phenylketonuria from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Phenylketonuria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Phenylketonuria

All Images
X-ray X-rays
Ultrasound Echo & Ultrasound
CT CT Images
MRI MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Phenylketonuria

CDC on Phenylketonuria

Phenylketonuria in the news

Blogs on Phenylketonuria

Directions to Hospitals Treating Phenylketonuria

Risk calculators and risk factors for Phenylketonuria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yanira Gavidia, M.D.

Overview

Phenylketonuria must be differentiated from other causes of intellectual developmental disability, seizures, anxiety/depression, and characteristic urine odors, such as other inborn errors of metabolism, cerebral palsy, inherited neurotransmitter disorders, and primary seizure disorders.

Differential Diagnosis

Phenylketonuria must be differentiated from other causes of intellectual developmental disability, seizures, anxiety/depression, and characteristic urine odors:[1][2][3][4]

Intellectual developmental disability

Seizures

  • Inherited neurotransmitter and non-neurotransmitter disorders
  • Primary seizure disorders

Anxiety and/or depression

Characteristic urine odor

References

  1. Leach EL, Shevell M, Bowden K, Stockler-Ipsiroglu S, van Karnebeek CD (2014). "Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review". Orphanet J Rare Dis. 9: 197. doi:10.1186/s13023-014-0197-2. PMC 4273454. PMID 25433678.
  2. Mercimek-Mahmutoglu S, Sidky S, Hyland K, Patel J, Donner EJ, Logan W; et al. (2015). "Prevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: a retrospective cohort study". Orphanet J Rare Dis. 10 (1): 12. doi:10.1186/s13023-015-0234-9. PMC 4342151. PMID 25758715.
  3. Zeltner NA, Huemer M, Baumgartner MR, Landolt MA (2014). "Quality of life, psychological adjustment, and adaptive functioning of patients with intoxication-type inborn errors of metabolism - a systematic review". Orphanet J Rare Dis. 9: 159. doi:10.1186/s13023-014-0159-8. PMC 4219016. PMID 25344299.
  4. Baumgartner MR, Hörster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA; et al. (2014). "Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia". Orphanet J Rare Dis. 9: 130. doi:10.1186/s13023-014-0130-8. PMC 4180313. PMID 25205257.

Template:WS Template:WH